SNST (Aphex BioCleanse Systems) Debt-to-Asset : 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aphex BioCleanse Systems Debt-to-Asset?

Aphex BioCleanse Systems SNST Debt-to-Asset is 0.00 as of . 20.

Aphex BioCleanse Systems's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was $0.00 Mil. Aphex BioCleanse Systems's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was $0.00 Mil.

Aphex BioCleanse Systems  (OTCPK:SNST) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Aphex BioCleanse Systems Debt-to-Asset Related Terms

Aphex BioCleanse Systems Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Debt-to-Asset Chart

Aphex BioCleanse Systems Annual Data
Trend
Debt-to-Asset

Aphex BioCleanse Systems Quarterly Data
Debt-to-Asset

Aphex BioCleanse Systems Debt-to-Asset Competitor Comparison

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems Debt-to-Asset vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Debt-to-Asset falls into.


Aphex BioCleanse Systems Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Aphex BioCleanse Systems's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Aphex BioCleanse Systems's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.00 mean?
Aphex BioCleanse Systems (SNST) has a Debt-to-Asset of 0.00 as of . 20. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Debt-to-Asset too high?
Aphex BioCleanse Systems' current Debt-to-Asset is 0.00.
How does Aphex BioCleanse Systems' Debt-to-Asset compare to competitors?
Aphex BioCleanse Systems' Debt-to-Asset of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Consumer Packaged Goods company?
A good Debt-to-Asset depends on the Consumer Packaged Goods industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Aphex BioCleanse Systems and its competitors. Aphex BioCleanse Systems's current Debt-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Debt-to-Asset of 0.00. The current Debt-to-Asset is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Debt-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.